- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
BTI cuts red ink as sales boom
Biomagnetic Technologies of San Diego reported a sharp increase in sales and a lower net loss for fiscal 1997 (end-September) as the company began recognizing revenue from magnetic source imaging systems that had been delayed from shipping in 1996. BTI
Biomagnetic Technologies of San Diego reported a sharp increase in sales and a lower net loss for fiscal 1997 (end-September) as the company began recognizing revenue from magnetic source imaging systems that had been delayed from shipping in 1996. BTI also reported that a European customer is developing a new version of its Magnes technology for applications other than the brain.
For the year, BTI posted revenues of $11 million, compared with $1.4 million in fiscal 1996, while the company's net loss shrank to $3 million, compared with $14.8 million the year before. BTI's revenues for the year included sales from the company's first Magnes 1300C system, which is being developed at the European site.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
